HEALTHCARE AI
“ The fully digitised sample can be explored , scrolled , and zoomed in and out by the clinician at 100x magnification – to the very fringes of the sample – without missing any details ”
ITAI HAYUT CEO AND CO-FOUNDER , SCOPIO LABS
increases workflow efficiency by up to 60 %, and thereby quickens the time for clinicians to make treatment decisions and initiation .”
AI & digitalisation can assist in the detection of blood cancers Scopio has not only created a superior workflow solution , but has broken the barrier of what is humanly possible with the age-old analogue , manual approach – and the positive impact of this cannot be overstated .
“ Currently , Scopio ’ s first FDA-cleared application , the Full- Field Peripheral Blood Smear Application , allows for PBS scanning , creating high-resolution images combined with a powerful AI-based Decision Support System to detect , pre-classify , and prequantify the cells ,” explains Hayut . “ Enabling the expert to view and analyse up to 200 cells with significantly greater speed and consistency , Scopio allows for complete remote review capabilities . In essence , Scopio has created a complete digital transformation of cell morphological analysis which completely supplants or replaces the manual microscope .”
Itai Hayut